Investors Grab ACAD 30.8% Cheaper Than Its Secondary Stock Offering
June 04, 2014 at 13:26 PM EDT
Looking back to 92 days ago, Acadia Pharmaceuticals Inc (ACAD) priced a 6,400,000 share secondary stock offering at $28.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..